Humoral Cytokine Levels in Patients with Herpes Zoster: A Meta-Analysis

References

• Mbinta JF, Wang AX, Nguyen BP, et al. Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study. Lancet Reg Health West Pac. 2023;31:100601. doi:10.1016/j.lanwpc.2022.100601
   PubMedGoogle Scholar
• Irigoyen-Mansilla VM, Gil-Prieto R, Gea-Izquierdo E, et al. Hospitalization burden related to herpes zoster infection during the COVID-19 pandemic in Spain (2020-2021). Hum Vaccin Immunother. 2023;19(2):2256047. doi:10.1080/21645515.2023.2256047
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang W-J, Xu S-X, et al. Propensity score matching comparing short-term nerve electrical stimulation to pulsed radiofrequency for herpes zoster-associated pain: a retrospective study. Front Mol Neurosci. 2022;15:1069058. doi:10.3389/fnmol.2022.1069058
   PubMed Web of Science ®Google Scholar
• Wen SY, Chao OY, Catherine KA, et al. Impact of type 1 versus type 2 diabetes on developing herpes zoster and post-herpetic neuralgia: a population-based cohort study. Acta Derm Venereol. 2023;103:adv9400. doi:10.2340/actadv.v103.9400
   PubMed Web of Science ®Google Scholar
• Pei J, Tian Y, Ye W, et al. A novel recombinant ORF7-siRNA delivered by flexible nano-liposomes inhibits varicella zoster virus infection. Cell Biosci. 2023;13(1):167. doi:10.1186/s13578-023-01108-1
   PubMed Web of Science ®Google Scholar
• de Oliveira Gomes J, Gagliardi AM, Andriolo BN, et al. Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev. 2023;10(10):Cd008858. doi:10.1002/14651858.CD008858.pub5
   PubMedGoogle Scholar
• Khazan M, Hedayati M, Robati RM, et al. Impaired oxidative status as a potential predictor in clinical manifestations of herpes zoster. J Med Virol. 2018;90(10):1604–1610. doi:10.1002/jmv.25204
   PubMed Web of Science ®Google Scholar
• Thomsen MM, Tyrberg T, Skaalum K, et al. Genetic variants and immune responses in a cohort of patients with varicella zoster virus encephalitis. J Infect Dis. 2021;224(12):2122–2132. doi:10.1093/infdis/jiab254
   PubMed Web of Science ®Google Scholar
• Boeren M, Meysman P, Laukens K, et al. T cell immunity in HSV-1- and VZV-infected neural ganglia. Trends Microbiol. 2023;31(1):51–61. doi:10.1016/j.tim.2022.07.008
   PubMed Web of Science ®Google Scholar
• Jin W, Fang M, Sayin I, et al. Differential CD4+ T-Cell cytokine and cytotoxic responses between reactivation and latent phases of herpes zoster infection. Pathog Immun. 2022;7(2):171–188. doi:10.20411/pai.v7i2.560
   PubMedGoogle Scholar
• Dery KJ, Wong Z, Wei M, et al. Mechanistic insights into alternative gene splicing in oxidative stress and tissue injury. Antioxid Redox Signal. 2023. doi:10.1089/ars.2023.0437
   Web of Science ®Google Scholar
• Dobrzyńska M, Moniuszko-Malinowska A, Skrzydlewska E. Metabolic response to CNS infection with flaviviruses. J Neuroinflammation. 2023;20(1):218. doi:10.1186/s12974-023-02898-4
   PubMed Web of Science ®Google Scholar
• Yang X, Liu X, Nie Y, et al. Oxidative stress and ROS-mediated cellular events in RSV infection: potential protective roles of antioxidants. Virol J. 2023;20(1):224. doi:10.1186/s12985-023-02194-w
   PubMed Web of Science ®Google Scholar
• Vatner SF, Zhang J, Oydanich M, et al. Healthful aging mediated by inhibition of oxidative stress. Ageing Res Rev. 2020;64:101194. doi:10.1016/j.arr.2020.101194
   PubMed Web of Science ®Google Scholar
• Hage FG. C-reactive protein and hypertension. J Hum Hypertens. 2014;28(7):410–415. doi:10.1038/jhh.2013.111
   PubMed Web of Science ®Google Scholar
• Yao Z, Zhang Y, Wu H. Regulation of C-reactive protein conformation in inflammation. Inflamm Res. 2019;68(10):815–823. doi:10.1007/s00011-019-01269-1
   PubMed Web of Science ®Google Scholar
• Pioli MR, de Faria AP. Pro-inflammatory cytokines and resistant hypertension: potential for novel treatments? Curr Hypertens Rep. 2019;21(12):95. doi:10.1007/s11906-019-1003-2
   PubMed Web of Science ®Google Scholar
• Sapartini G, Wong GWK, Indrati AR, et al. The association between vitamin d, interleukin-4, and interleukin-10 levels and CD23+ expression with bronchial asthma in stunted children. Biomedicines. 2023;11(9):2542. doi:10.3390/biomedicines11092542
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Liverpool, UK: University of Liverpool; 2011.
   Google Scholar
• Zak-Prelich M, Mckenzie RC, Sysa-Jedrzejowska A, et al. Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia. Clin Exp Immunol. 2003;131(2):318–323. doi:10.1046/j.1365-2249.2003.02061.x
   PubMed Web of Science ®Google Scholar
• Zhu SM, Liu Y-M, An E-D, et al. Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia. J Zhejiang Univ Sci B. 2009;10(8):625–630. doi:10.1631/jzus.B0920049
   PubMed Web of Science ®Google Scholar
• Zhang M, Wu N, Yang L, et al. Study on the T-helper cell 1/2 cytokine profile in blister fluid of patients with herpes zoster and its clinical significance. J Dermatol. 2011;38(12):1158–1162. doi:10.1111/j.1346-8138.2011.01289.x
   PubMed Web of Science ®Google Scholar
• Zajkowska A, Garkowski A, Świerzbińska R, et al. Evaluation of chosen cytokine levels among patients with herpes zoster as ability to provide immune response. PLoS One. 2016;11(3):e0150301. doi:10.1371/journal.pone.0150301
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang Y, Fang Q, et al. Changes in neurotrophic and inflammatory factors in the cerebrospinal fluid of patients with postherpetic neuralgia. Neurosci Lett. 2017;637:108–113. doi:10.1016/j.neulet.2016.11.041
   PubMed Web of Science ®Google Scholar
• Wei L, Zhao J, Wu W, et al. Decreased absolute numbers of CD3(+) T cells and CD8(+) T cells during aging in herpes zoster patients. Sci Rep. 2017;7(1):15039. doi:10.1038/s41598-017-15390-w
   PubMedGoogle Scholar
• Khazan M, Nasiri S, Riahi SM, et al. Measurement of melatonin, indole-dioxygenase, IL-6, IL-18, ferritin, CRP, and total homocysteine levels during herpes zoster. J Med Virol. 2020;92(8):1253–1259. doi:10.1002/jmv.25484
   PubMed Web of Science ®Google Scholar
• Fukuyasu A, Kamata M, Sy Hau C, et al. Serum interleukin-10 level increases in patients with severe signs or symptoms of herpes zoster and predicts the duration of neuralgia. J Dermatol. 2021;48(4):511–518. doi:10.1111/1346-8138.15818
   PubMed Web of Science ®Google Scholar
• Yang X, Shen Y, Ding Z, et al. Circulating level of myelin basic protein predicts postherpetic neuralgia: a prospective study. Clin J Pain. 2021;37(6):429–436. doi:10.1097/AJP.0000000000000937
   PubMed Web of Science ®Google Scholar
• Oskay T, Keskin C, Özen M. Antioxidant and inflammatory biomarkers in herpes zoster. J Med Virol. 2022;94(8):3924–3929. doi:10.1002/jmv.27781
   PubMed Web of Science ®Google Scholar
• Lin D, Zhong C, Jiang Q, et al. Serum interleukin-6 levels are increased in post-herpetic neuralgia: a single-center retrospective study. An Bras Dermatol. 2023;98(2):202–207. doi:10.1016/j.abd.2022.03.007
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhang Y, Wang J, et al. Immune changes and their relationship with prognosis in patients with varicella-zoster virus encephalitis/meningitis. Am J Transl Res. 2023;15(2):1421–1429.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi:10.1186/1471-2288-14-135
   PubMed Web of Science ®Google Scholar
• McGrath S, Zhao X, Steele R, et al. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis. Stat Methods Med Res. 2020;29(9):2520–2537. doi:10.1177/0962280219889080
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Le P, Rothberg M. Herpes zoster infection. BMJ. 2019;364:k5095. doi:10.1136/bmj.k5095
   PubMed Web of Science ®Google Scholar
• Stöberl N, Maguire E, Salis E, et al. Human iPSC-derived glia models for the study of neuroinflammation. J Neuroinflammation. 2023;20(1):231. doi:10.1186/s12974-023-02919-2
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Tanaka T. Interleukin 6 and rheumatoid arthritis. Biomed Res Int. 2014;2014:698313. doi:10.1155/2014/698313
   PubMed Web of Science ®Google Scholar
• Arruda JL, Sweitzer S, Rutkowski MD, et al. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain 11 Published on the world wide web on 28 August 2000. Brain Res. 2000;879(1–2):216–225. doi:10.1016/S0006-8993(00)02807-9
   PubMed Web of Science ®Google Scholar
• Jarosinski KW, Carpenter JE, Buckingham EM, et al. Cellular stress response to varicella-zoster virus infection of human skin includes highly elevated interleukin-6 expression. Open Forum Infect Dis. 2018;5(6):ofy118. doi:10.1093/ofid/ofy118
   PubMed Web of Science ®Google Scholar
• Xing Q, Hu D, Shi F, et al. Role of regulatory T cells in patients with acute herpes zoster and relationship to postherpetic neuralgia. Arch Dermatol Res. 2013;305(8):715–722. doi:10.1007/s00403-013-1367-0
   PubMed Web of Science ®Google Scholar
• Cho JW, Shin DH, Lee KS. Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster in Korea. J Dermatol Sci. 2007;45(3):213–215. doi:10.1016/j.jdermsci.2006.11.004
   PubMed Web of Science ®Google Scholar
• Akdis M, Burgler S, Crameri R, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127(3):701–21. doi:10.1016/j.jaci.2010.11.050
   PubMed Web of Science ®Google Scholar
• Gruys E, Toussaint MJM, Niewold TA, et al. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 2005;6(11):1045–1056. doi:10.1631/jzus.2005.B1045
   PubMedGoogle Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
   PubMed Web of Science ®Google Scholar
• Pushpakumar S, Kundu S, Sen U. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Curr Med Chem. 2014;21(32):3662–3672. doi:10.2174/0929867321666140706142335
   PubMed Web of Science ®Google Scholar
• Sharma M, Tiwari M, Tiwari RK. Hyperhomocysteinemia: impact on neurodegenerative diseases. Basic Clin Pharmacol Toxicol. 2015;117(5):287–296. doi:10.1111/bcpt.12424
   PubMed Web of Science ®Google Scholar
• Zahedi AS, Daneshpour MS, Akbarzadeh M, et al. Association of baseline and changes in adiponectin, homocysteine, high-sensitivity C-reactive protein, interleukin-6, and interleukin-10 levels and metabolic syndrome incidence: Tehran lipid and glucose study. Heliyon. 2023;9(9):e19911. doi:10.1016/j.heliyon.2023.e19911
   PubMed Web of Science ®Google Scholar
• Shemirani F, Titcomb TJ, Saxby SM, et al. Association of serum homocysteine, folate, and vitamin B(12) and mood following the Swank and Wahls elimination dietary interventions in relapsing-remitting multiple sclerosis: secondary analysis of the WAVES trial. Mult Scler Relat Disord. 2023;75:104743. doi:10.1016/j.msard.2023.104743
   PubMed Web of Science ®Google Scholar
• Vukmanovic-Stejic M, Sandhu D, Seidel JA, et al. The characterization of varicella zoster virus-specific T cells in skin and blood during aging. J Invest Dermatol. 2015;135(7):1752–1762. doi:10.1038/jid.2015.63
   PubMed Web of Science ®Google Scholar
• Ku CC, Besser J, Abendroth A, et al. Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol. 2005;79(5):2651–2658. doi:10.1128/JVI.79.5.2651-2658.2005
   PubMed Web of Science ®Google Scholar
• Jiménez M, Fernández‐Naval C, Navarro V, et al. Kinetics of cellular and humoral immunogenicity and effectiveness of SARS-CoV −2 booster vaccination in hematologic neoplasms. Am J Hematol. 2023;98(8):1204–1213. doi:10.1002/ajh.26951
   PubMed Web of Science ®Google Scholar
• Liang X, Fan Y. Bidirectional two-sample Mendelian randomization analysis reveals a causal effect of interleukin-18 levels on postherpetic neuralgia risk. Front Immunol. 2023;14:1183378. doi:10.3389/fimmu.2023.1183378
   PubMed Web of Science ®Google Scholar
• Gershon AA, Gershon MD, Breuer J, et al. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010;48(Suppl 1):S2–7. doi:10.1016/S1386-6532(10)70002-0
   PubMed Web of Science ®Google Scholar
• Forstenpointner J, Rice ASC, Finnerup NB, et al. Up-date on clinical management of postherpetic neuralgia and mechanism-based treatment: new options in therapy. J Infect Dis. 2018;218(suppl_2):S120–s126. doi:10.1093/infdis/jiy381
   PubMed Web of Science ®Google Scholar
• Li H, Li X, Wang J, et al. Pain-related reorganization in the primary somatosensory cortex of patients with postherpetic neuralgia. Hum Brain Mapp. 2022;43(17):5167–5179. doi:10.1002/hbm.25992
   PubMed Web of Science ®Google Scholar
• Fan X, Ren H, Bu C, et al. Alterations in local activity and functional connectivity in patients with postherpetic neuralgia after short-term spinal cord stimulation. Front Mol Neurosci. 2022;15:938280. doi:10.3389/fnmol.2022.938280
   PubMed Web of Science ®Google Scholar
• Peng Q, Guo X, Luo Y, et al. Dynamic Immune Landscape and VZV-Specific T cell responses in patients with herpes zoster and postherpetic neuralgia. Front Immunol. 2022;13:887892. doi:10.3389/fimmu.2022.887892
   PubMed Web of Science ®Google Scholar
• Anosike UG, Ouko I, Mwaura AW, et al. Phenotypes and genotypes in postherpetic neuralgia drug therapy: a narrative mini-review. Clin J Pain. 2022;38(8):536–540. doi:10.1097/AJP.0000000000001045
   PubMed Web of Science ®Google Scholar
• Nishizawa D, Iseki M, Arita H, et al. Genome-wide association study identifies candidate loci associated with chronic pain and postherpetic neuralgia. Mol Pain. 2021;17:1744806921999924. doi:10.1177/1744806921999924
   Web of Science ®Google Scholar
• Xing X, Bai Y, Sun K, et al. Identification of candidate genes associated with postherpetic neuralgia susceptibility. Pain Physician. 2020;23(3):E281–e288.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Hemalatha S. Sida cordifolia L. attenuates behavioral hypersensitivity by interfering with KIF17-NR2B signaling in rat model of neuropathic pain. J Ethnopharmacol. 2023;319(Pt 1):117085. doi:10.1016/j.jep.2023.117085
   PubMedGoogle Scholar
• Sheu ML, Pan L-Y, Yang C-N, et al. Neuronal death caused by HMGB1-evoked via inflammasomes from thrombin-activated microglia cells. Int J Mol Sci. 2023;24(16):12664. doi:10.3390/ijms241612664
   PubMed Web of Science ®Google Scholar
• Koop MA, Sleijser-Koehorst MLS, Hooijmans CR, et al. The potential protective effects of pre-injury exercise on neuroimmune responses following experimentally-induced traumatic neuropathy: a systematic review with meta-analysis. Front Immunol. 2023;14:1215566. doi:10.3389/fimmu.2023.1215566
   PubMed Web of Science ®Google Scholar
• Wan S, Chen Q, Xiang Y, et al. Interleukin-1 increases cyclooxygenase-2 expression and prostaglandin E2 production in human granulosa-lutein cell via nuclear factor kappa B/P65 and extracellular signal-regulated kinase 1/2 signaling pathways. Mol Cell Endocrinol. 2023;566–567:111891. doi:10.1016/j.mce.2023.111891
   PubMed Web of Science ®Google Scholar
• Laughlin TM, Bethea JR, Yezierski RP, et al. Cytokine involvement in dynorphin-induced allodynia. Pain. 2000;84(2–3):159–167. doi:10.1016/S0304-3959(99)00195-5
   PubMed Web of Science ®Google Scholar
• Liao Z, Zhu Q, Huang H. Involvement of IL-1β-mediated necroptosis in neurodevelopment impairment after neonatal sepsis in rats. Int J Mol Sci. 2023;24(19):14693. doi:10.3390/ijms241914693
   PubMed Web of Science ®Google Scholar
• Xu X, Liu Z, Liu H, et al. The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2012;680(1–3):28–33. doi:10.1016/j.ejphar.2012.01.011
   PubMed Web of Science ®Google Scholar
• Yang XM, He RG. 牛痘疫苗致炎兔皮提取物治疗老年带状疱疹后遗神经痛及对血清IL-6的影响 [Effect of extracts from rabbit skin inflamed by vaccinia virus in the management of postherpetic neuralgia and on serum interleukin-6 level in aged patients]. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27(12):1941–1943. Chinese.
   PubMedGoogle Scholar
• Committee for the Development of Pain Clinic Treatment Guidelines, Japan Pain Clinic Society. Treatment CoGf. J Jpn Soc Pain Clin. 2010;17:S55–S134.
   Google Scholar
• Werner RN, Nikkels AF, Marinović B, et al. European consensus-based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: diagnosis. J Eur Acad Dermatol Venereol. 2017;31(1):9–19. doi:10.1111/jdv.13995
   PubMed Web of Science ®Google Scholar
• Liu C, Chu D, Kalantar‐Zadeh K, et al. Cytokines: from clinical significance to quantification. Adv Sci. 2021;8(15):e2004433. doi:10.1002/advs.202004433
   Web of Science ®Google Scholar
• De Preter V. Metabolomics in the clinical diagnosis of inflammatory bowel disease. Dig Dis. 2015;33(1):2–10. doi:10.1159/000437033
   PubMedGoogle Scholar
• Chen W, Zhu L, Shen -L-L, et al. T lymphocyte subsets profile and toll-like receptors responses in patients with herpes zoster. J Pain Res. 2023;16:1581–1594. doi:10.2147/JPR.S405157
   PubMed Web of Science ®Google Scholar